The Lymphatic Education & Research Network (LE&RN) is pleased to announce the Jane Petty Translational Science Catalyst Award, a new funding opportunity created to accelerate the path from discovery to patient impact in lymphatic diseases. Established in honor of Jane Petty’s commitment to advancing lymphatic research, this award supports innovative projects that hold clear potential to improve diagnosis, treatment, prevention, or care for people living with lymphatic diseases.
About the Award
The award provides up to $60,000 over two years to support early-stage, translational research with strong clinical relevance and near-term potential to benefit patients. Projects may be laboratory-based, epidemiologic, or population-level studies, provided they demonstrate tangible translational impact.
Who Should Apply
The program is open to early- to mid-career investigators (postdoctoral researchers through assistant professors) from academic, medical, nonprofit, small business, or research institutions worldwide. Awardees will join LE&RN’s global network of scientists, clinicians, and advocates dedicated to transforming outcomes for those affected by lymphatic diseases.
Key Focus Areas
- Early diagnosis, detection, and imaging innovations
- Translational therapeutics and disease mechanisms
- Epidemiology and health disparities
- Biomarker and digital tool development
- Lymphatic vessel biology and cross-system integration
Award Highlights
- $60,000 in total funding over two years (no indirect costs)
- Supports proof-of-concept, pilot data, and feasibility studies
- Open to applicants worldwide
Application Process & Timeline
- All applications must be submitted through grant application portal – Proposal Central
- Letter of Intent (LOI) deadline: 27 October 2025
- Full proposal deadline: 10 November 2025
- Notice of Award: January 2026
Learn More
Find full details and application instructions here.
To apply for this award through Proposal Central, click here.